Business Issues/Benchmarks: Page 4

Pre-Rolls Surpass Flower as Canada’s Top-Earning Cannabis Category

An industry report released by Custom Cones USA highlights the market trends and the top 50 Canadian pre-roll brands of 2025.

Massachusetts Medical Cannabis Sales Drop 40% Since 2021 Peak

The state’s medical cannabis dispensary sales make up 9% of the total retail market as consumers have increasingly gravitated toward adult use.

LEVIA Original Founders Reacquiring Cannabis Beverage Brand From Ayr Wellness

Kristin and Eric Rogers signed a definitive agreement to take back the Massachusetts-based brand that’s been on the market since 2021.

Whitney Economics Issues US Cannabis and Hemp Beverage Report: THC Beverage Sales Top $1.1 Billion in 2024

The report examines the emerging THC beverage industry from a policy and regulatory perspective, addressing demand by state, and providing an estimate of current and future legal sales.

Bountiful Farms Expands to Adult-Use Retail With Plans to Open 2 Massachusetts Dispensaries

The licensed cultivator and wholesaler is planning grand openings later this month at stores in Rowley and Framingham.

Nebraska Commission Deviates From Voters’ Will on Medical Cannabis

The state’s Medical Cannabis Commission approved regulations that ban cannabis flower, vapes and edibles, and limit the number of business licenses.

True Harmony Launches State-of-the-Art Cannabis Cultivation Facility in Nevada

The 250,000-square-foot glasshouse facility is designed to optimize mixed-light cultivation techniques.

Green Thumb Workers Strike at Pennsylvania RISE Dispensary

The cannabis retail workers in York, Pa., went on strike after their union representatives filed allegations with the National Labor Relations Board.

Glass House Brands Board Member Dies

The California cannabis company announced the death of George Raveling.

Standard Wellness Acquires Greenstock, Expands Ohio Dispensary Footprint

The cannabis company’s $1.35 million acquisition is for a fourth retail facility in the Buckeye State.

High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest.

The Cannabis Business Growth Guide: Unlocking Banking, Partnerships, and Scale

Green Check

Previous Page

Page 4 of 523

Next Page